The adjusted trial balance of Concord Company and other related information for the year 2017 are presented as follows. Prepare a balance sheet as of December 31, 2017, so that all important information is fully disclosed.

CONCORD COMPANY ADJUSTED TRIAL BALANCE DECEMBER 31, 2017
	Debit		Credit
Cash	$ 43,410
Accounts Receivable	165,910
Allowance for Doubtful Accounts			$ 9,120
Prepaid Insurance	6,320
Inventory	210,910
Equity Investments (long-term)	341,410
Land	87,410
Construction in Progress (building)	126,410
Patents	36,000
Equipment	402,410
Accumulated Depreciation-Equipment			240,420
Discount on Bonds Payable	20,000
Accounts Payable			150,410
Accrued Liabilities			51,610
Notes Payable			96,410
Bonds Payable			202,410
Common Stock			502,410
Paid-in Capital in Excess of Par-Common Stock			45,000
Retained Earnings			142,400
	$1,440,190		$1,440,190

Additional information:

1.		The LIFO method of inventory value is used.
2.		The cost and fair value of the long-term investments that consist of stocks and bonds is the same.
3.		The amount of the Construction in Progress account represents the costs expended to date on a building in the process of construction. (The company rents factory space at the present time.) The land on which the building is being constructed cost $87,410, as shown in the trial balance.
4.		The patents were purchased by the company at a cost of $40,000 and are being amortized on a straight-line basis.
5.		Of the discount on bonds payable, $2,000 will be amortized in 2018.
6.		The notes payable represent bank loans that are secured by long-term investments carried at $122,410. These bank loans are due in 2018.
7.		The bonds payable bear interest at 8% payable every December 31, and are due January 1, 2028.
		600,000 shares of common stock of a par value of $1 were authorized, of which 502,410 shares were issued and outstanding